New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Eikon Therapeutics, Inc. (EIKN) vs Ocugen, Inc. (OCGN)
- Eikon Therapeutics, Inc. EIKN 4.74 −0.42%
- Ocugen, Inc. OCGN 0.77 +5.48%
Eikon Therapeutics, Inc. and Ocugen, Inc. are both Biotechnology companies. Eikon Therapeutics, Inc. and Ocugen, Inc. are of similar size ($257.9M and $248.6M). Across the 8 metrics below, Ocugen, Inc. leads on 6 and Eikon Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | EIKN | OCGN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | — | (1,444.47%) | 0.00% |
| Net margin | — | (1,367.61%) | 0.00% |
| Free cash flow margin | — | (1,337.16%) | 0.00% |
| Return on equity | 359.35% | 923.92% | (51.58%) |
| Return on assets | (56.31%) | (78.91%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack